Results 141 to 150 of about 99,108 (283)

Global cardiometabolic alliance: A clinical and research initiative addressing the 21st century pandemic of insulin resistance‐associated disease

Diabetes, Obesity and Metabolism, Volume 27, Issue 11, Page 6101-6104, November 2025.
Robert H. Eckel, Andrew J. Krentz, Stephan Jacob, Peter Libby   +3 more
wiley   +1 more source

A New Polymer‐Coated Xenogeneic Extracellular Matrix to Prevent Postoperative Adhesion Readily Applicable in the Clinic

Macromolecular Bioscience, Volume 25, Issue 10, October 2025.
Postoperative adhesions remain a major challenge in neurosurgery, increasing reoperation risks and complications. This study presents an initiated chemical vapor deposition (iCVD)‐based polymer coating for dura substitutes, significantly reducing adhesion formation.
Kyung Hyun Kim, Younghak Cho, Yunyoung Choi, Seeun Jeon, Yun Jin Lee, Hyejeong Seong, Ji Yeoun Lee   +6 more
wiley   +1 more source

FIBRINOLYSIS IN MYOCARDIAL INFARCTION

, 1958
Robert Hume
openalex   +1 more source

Pathogenesis of Fibrinolysis in Defibrination Syndrome: Effect of Heparin Administration [PDF]

, 1964
C. Merskey, Alan J. Johnson, James H. Pert, Herbert Wohl   +3 more
openalex   +1 more source

Caveolin‐1 Is a Central Mediator of Acute Lung Injury in an Animal Model of Sickle Cell Disease

Pulmonary Circulation, Volume 15, Issue 4, October 2025.
ABSTRACT Acute chest syndrome in sickle cell disease (SCD) carries high morbidity and mortality, with up to 15% of patients requiring invasive mechanical ventilation. However, the rates and mechanisms of ventilator‐induced lung injury (VILI) in SCD remain poorly understood.
Clare C. Prohaska, Justin R. Sysol, Nicole Jones, Robert W. Wysocki, Suellen D. Oliveira, Richard D. Minshall, Roberto F. Machado   +6 more
wiley   +1 more source

Use of Affimer technology for inhibition of α2-antiplasmin and enhancement of fibrinolysis

Blood Advances
:: Hypofibrinolysis is a documented abnormality in conditions with high risk of vascular occlusion. A key inhibitor of fibrinolysis is α2-antiplasmin (α2AP), and we hypothesize that the Affimer technology, comprising small conformational proteins with 2 ...
Nikoletta Pechlivani, Basmah Alsayejh, Mansour Almutairi, Katie Simmons, Thembaninkosi Gaule, Fladia Phoenix, Noppadol Kietsiriroje, Sreenivasan Ponnambalam, Cédric Duval, Robert A.S. Ariëns, Christian Tiede, Darren C. Tomlinson, Ramzi A. Ajjan   +12 more
doaj   +1 more source

Effects of three cobra venoms on blood coagulation, platelet aggregation, and fibrinolysis [PDF]

, 1969
Nancy MacKay, Jenny Ferguson, G. P. McNicol   +2 more
openalex   +1 more source

LPAR1 Promotes Activation of Pathways Alveolar Hypercoagulation and Fibrinolytic Inhibition in ARDS via NF‐κB Signaling Pathway

FASEB BioAdvances, Volume 7, Issue 10, October 2025.
ABSTRACT Alveolar hypercoagulation and fibrinolytic inhibition are critical mechanisms contributing to refractory hypoxemia in acute respiratory distress syndrome (ARDS). The nuclear factor kappa‐B (NF‐κB) pathway is known to play a role in these processes.
Ying Liu, Xianjun Chen, Meng Liu, Jia Yuan, Qing Li, Lu Li, Qi Dong, Junling Tao, Feng Shen, Chuan Xiao   +9 more
wiley   +1 more source

STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. III. A QUANTITATIVE METHOD FOR THE ESTIMATION OF SERUM ANTIFIBRINOLYSIN 1

, 1946
Melvin H. Kaplan
openalex   +1 more source

Pharmacological enhancement of fibrinolysis. [PDF]

, 1969
G. R. Fearnley, Ranjan Chakrabarti
openalex   +1 more source